Research and Markets has announced the addition of the "Antibiotics Market Analysis By Drug Class, By Mechanism Of Action And Segment Forecasts To 2024" report to their offering.

The antibiotics market is expected to reach USD 57 billion by 2024. Rising prevalence of infectious diseases especially in developing regions such as Asia Pacific and MEA is anticipated to contribute towards market growth.

More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.

Government reforms specific to antibiotics such as the Generating Antibiotics Incentives Now (GAIN) Act in the U.S. are projected to help market growth over the forecast period. This further expected facilitate development of advanced drugs.

On the contrary, uncertain regulatory policies are likely to hinder the growth of this vertical impacting market growth significantly. In 2013, the U.S. FDA revised the guidance for registration trials for drugs used in the treatment of acute bacterial skin and skin structure infections. The guidance states the use of short term measures of anti-infective efficacy (percent reduction in lesion size at 48 to 72 hours) as opposed to long term measures such as resolution of infection at 10-14 days, which is termed as Test to Cure or TOC.

Companies Mentioned:

  • Getinge Group
  • Hill-Rom
  • Invacare Corporation
  • Joerns Healthcare, LLC
  • Argo Medical, Inc.
  • Prism Medical
  • DJO Global
  • V.Guldmann A/S
  • Spectra Care Group
  • Drive Medical

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Market Summary

4 Market Variables, Trends & Scope

5 Drug Class Estimates & Trend Analysis

6 Mechanism Estimates & Trend Analysis

7 Regional Estimates & Trend Analysis

8 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/gxcdhf/antibiotics